Antiplasmin - The forgotten serpin?

被引:46
作者
Coughlin, PB [1 ]
机构
[1] Monash Univ, Australian Ctr Blood Dis, Prahran, Vic 3181, Australia
关键词
antiplasmin; fibrinolysis; plasminogen; serpinF2;
D O I
10.1111/j.1742-4658.2005.04881.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Much of the basic biochemistry of antiplasmin was described more than 20 years ago and yet it remains an enigmatic member of the serine protease inhibitor (serpin) family. It possesses all of the characteristics of other inhibitory serpins but in addition it has unique N- and C-terminal extensions which significantly modify its activities. The N-terminus serves as a substrate for Factor XIIIa leading to crosslinking and incorporation of antiplasmin into a clot as it is formed. Although free antiplasmin is an excellent inhibitor of plasmin, the fibrin bound form of the serpin appears to be the major regulator of clot lysis. The C-terminal portion of antiplasmin is highly conserved between species and contains several charged amino acids including four lysines with one of these at the C-terminus. This portion of the molecule mediates the initial interaction with plasmin and is a key component of antiplasmin's rapid and efficient inhibitory mechanism. Studies of mice with targeted deletion of antiplasmin have confirmed its importance as a major regulator of fibrinolysis and re-emphasized its value as a potential therapeutic target.
引用
收藏
页码:4852 / 4857
页数:6
相关论文
共 33 条
[11]  
KLUFT C, 1986, BLOOD, V67, P616
[12]  
KOIE K, 1978, LANCET, V2, P1334
[13]   DIFFERENT NH2-TERMINAL FORM WITH 12 ADDITIONAL RESIDUES OF ALPHA(2)-PLASMIN INHIBITOR FROM HUMAN PLASMA AND CULTURE MEDIA OF HEP G2 CELLS [J].
KOYAMA, T ;
KOIKE, Y ;
TOYOTA, S ;
MIYAGI, F ;
SUZUKI, N ;
AOKI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) :417-422
[14]   Cross-linking of wild-type and mutant α2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase [J].
Lee, KN ;
Lee, CS ;
Tae, WC ;
Jackson, KW ;
Christiansen, VJ ;
McKee, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37382-37389
[15]   A novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestion [J].
Lee, KN ;
Jackson, KW ;
Christiansen, VJ ;
Chung, KH ;
McKee, PA .
BLOOD, 2004, 103 (10) :3783-3788
[16]   Effect of a synthetic carboxy-terminal peptide of α2-antiplasmin on urokinase-induced fibrinolysis [J].
Lee, KN ;
Jackson, KW ;
McKee, PA .
THROMBOSIS RESEARCH, 2002, 105 (03) :263-270
[17]   Characterization of wild-type and mutant α2-antiplasmins:: Fibrinolysis enhancement by reactive site mutant [J].
Lee, KN ;
Tae, WC ;
Jackson, KW ;
Kwon, SH ;
McKee, PA .
BLOOD, 1999, 94 (01) :164-171
[18]   AMINO-ACID-SEQUENCE OF HUMAN ALPHA-2-ANTIPLASMIN [J].
LIJNEN, HR ;
HOLMES, WE ;
VANHOEF, B ;
WIMAN, B ;
RODRIGUEZ, H ;
COLLEN, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 166 (03) :565-574
[19]   α2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding [J].
Lijnen, HR ;
Okada, K ;
Matsuo, O ;
Collen, D ;
Dewerchin, M .
BLOOD, 1999, 93 (07) :2274-2281
[20]   Gene targeting in hemostasis.: Alpha2-antiplasmin [J].
Lijnen, HR .
FRONTIERS IN BIOSCIENCE, 2001, 6 :D239-D247